Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Privium Fund Management B.V. (CIK 1795097) reported $480.3M across 60 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: TSLA ($82.5M, 17.18%), SHOP ($48.3M, 10.05%), SPOT ($32.5M, 6.76%), PLTR ($29.3M, 6.09%), AMZN ($26.0M, 5.42%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | TSLA | TESLA INC | $82.5M | 17.18% | 222,000 | Trimmed |
| 2 | SHOP | SHOPIFY INC | $48.3M | 10.05% | 407,000 | Trimmed |
| 3 | SPOT | SPOTIFY TECHNOLOGY S A | $32.5M | 6.76% | 67,000 | Trimmed |
| 4 | PLTR | PALANTIR TECHNOLOGIES INC | $29.3M | 6.09% | 200,000 | Hold |
| 5 | AMZN | AMAZON COM INC | $26.0M | 5.42% | 125,000 | Added |
| 6 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $23.0M | 4.79% | 366,936 | Trimmed |
| 7 | IONS | IONIS PHARMACEUTICALS INC | $21.8M | 4.53% | 290,024 | Added |
| 8 | LMND | LEMONADE INC | $16.0M | 3.33% | 255,259 | Added |
| 9 | NVDA | NVIDIA CORPORATION | $14.1M | 2.94% | 81,000 | Hold |
| 10 | COIN | COINBASE GLOBAL INC | $13.8M | 2.87% | 79,000 | Hold |
| 11 | AMD | ADVANCED MICRO DEVICES INC | $12.6M | 2.63% | 62,000 | Added |
| 12 | ASTS | AST SPACEMOBILE INC | $12.0M | 2.50% | 145,000 | Hold |
| 13 | SE | SEA LTD | $11.4M | 2.38% | 138,000 | Hold |
| 14 | IREN | IREN LIMITED | $11.0M | 2.28% | 320,150 | Added |
| 15 | AXSM | AXSOME THERAPEUTICS INC. | $9.9M | 2.07% | 58,729 | Added |
| 16 | ESPR | ESPERION THERAPEUTICS INC NE | $9.0M | 1.88% | 3.3M | New |
| 17 | PRQR | PROQR THRAPEUTICS N V | $8.9M | 1.84% | 5.5M | Added |
| 18 | BIIB | BIOGEN INC | $8.0M | 1.67% | 43,800 | Trimmed |
| 19 | QURE | UNIQURE NV | $8.0M | 1.66% | 486,520 | Added |
| 20 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $7.6M | 1.59% | 364,802 | Added |
| 21 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $7.6M | 1.57% | 320,972 | Added |
| 22 | BMRN | BIOMARIN PHARMACEUTICAL INC | $5.2M | 1.09% | 92,305 | New |
| 23 | VRTX | VERTEX PHARMACEUTICALS INC | $5.1M | 1.06% | 11,355 | Added |
| 24 | DNLI | DENALI THERAPEUTICS INC | $4.9M | 1.02% | 254,857 | New |
| 25 | URGN | UROGEN PHARMA LTD | $4.3M | 0.89% | 238,122 | Added |
Source: SEC Form 13F filings · as of 2026-03-31